IMV Provides Update on Progress of its DPX-RSV Program
BioTech Gate,
New Proof of Concept Animal Health Data Validate RSV Vaccine Candidate’s Novel Mechanism of Action and Its Potential to Impact…
New Proof of Concept Animal Health Data Validate RSV Vaccine Candidate’s Novel Mechanism of Action and Its Potential to Impact…
DARTMOUTH, Nova Scotia, Sept. 27, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology…
GlobeNewswire 2018-09-27 New Proof of Concept Animal Health Data Validate RSV Vaccine Candidate’s Novel Mechanism of Action and…
DARTMOUTH, Nova Scotia, Sept. 27, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (NASDAQ:IMV, TSX:IMV), a clinical stage immuno-oncology…